Recalls / Class II

Class IID-782-2013

Product

Sodium Tetradecyl Sulfate (0.125%, 1%, 2.5%, 3%, and 4%) Injection, compounded by Olympia Pharmacy, Orlando, FL

Affected lot / code info

0.125% Lot B3505 Exp 8/1/13 // 1% Lots C5001 Exp 9/30/13, C5406 Exp 9/4/13, and C5306 Exp 9/30/13 // 2.5% Lot C5101 Exp 9/30/13 // 3% Lots B5120 Exp 10/31/13, C5301 Exp 9/30/13, B5428 Exp 6/4/13, and C5212 Exp 9/21/13 // 4% Lot C5301 Exp 9/30/13

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Recalling firm

Firm

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Notification channel

Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Type

Voluntary: Firm initiated

Address

6700 Conroy Windermere Rd, Suite 140, Orlando, Florida 32835-3500

Distribution

Quantity

10

Distribution pattern

Nationwide and PR

Timeline

Recall initiated

2013-05-29

FDA classified

2013-07-11

Posted by FDA

2013-07-17

Status

Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-782-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.